Benefits
Antioxidant defense support
Selenium from high-selenium yeast supplies the body with the building blocks for selenium-dependent enzymes such as glutathione peroxidases, which help neutralize free radicals. In the one trial that tested this brand, 69 healthy men took selenium yeast, plain selenomethionine or placebo for 9 months. The higher dose of selenium yeast (285 µg/day) lowered two urinary markers of oxidative stress by about 34% and 28%, while plain selenomethionine changed neither. Both markers returned to their starting values within 3 months of stopping. This is a small, men-only study of lab markers, and it did not measure whether those marker changes translate into any health benefit.
Healthy immune function
Adequate selenium status helps maintain normal immune cell activity and the body's antioxidant protection of immune tissues. Selenoproteins take part in inflammatory and immune signaling, which is why adequate selenium intake matters. That is background nutrient biology rather than a tested effect of this product: none of the studies cited on this page measured immune cell activity, inflammation, infections or illness.
Normal thyroid metabolism
The thyroid gland is one of the most selenium-rich tissues in the body. Selenium-dependent deiodinase enzymes help convert thyroid hormone into its active form, and selenoproteins protect thyroid tissue from oxidative byproducts. That is why selenium matters for thyroid biology. It is background nutrient science, not a tested effect of this product: none of the studies cited on this page measured thyroid hormones, thyroid antibodies or any thyroid outcome.
Food-form bioavailability
As an organically bound, yeast-derived selenium source, SelenoExcell® delivers selenium primarily as selenomethionine, the same form found in selenium-rich foods. Selenomethionine is taken up in place of methionine when the body builds proteins, which creates a store of selenium. The studies cited here did not compare how much selenium is absorbed from different forms, although the 9-month trial did find that the yeast form and pure selenomethionine behaved differently on oxidative stress markers.
Maintains healthy selenium status
Selenium content in food varies with the soil where it was grown, so intake differs from region to region, and a standardized high-selenium yeast raises blood selenium in people whose intake is low. More is not better. In the large trials cited on this page, extra selenium did not prevent cancer, one analysis found more squamous cell skin cancer in the selenium group, and a very large trial saw a non-significant signal toward more type 2 diabetes. If you are unsure of your status, a blood test and a conversation with your clinician make more sense than guessing.
Mechanism of action
Glutathione peroxidase synthesis
Selenium is incorporated as selenocysteine into glutathione peroxidase enzymes. These enzymes reduce hydrogen peroxide and lipid peroxides, forming a frontline antioxidant defense that protects cell membranes and DNA from oxidative damage.
Selenomethionine protein incorporation
Yeast-derived selenomethionine is non-specifically incorporated into body proteins in place of methionine, creating a selenium reservoir. This stored selenium is gradually released and used to synthesize functional selenoproteins as the body requires them.
Thyroid deiodinase activity
Selenium-containing iodothyronine deiodinases convert thyroxine (T4) into the metabolically active triiodothyronine (T3). Sufficient selenium supports normal activity of these enzymes and helps protect the thyroid from peroxide generated during hormone synthesis.
Redox signaling and thioredoxin support
Selenoproteins such as thioredoxin reductase help regulate the cell's redox state and support normal cell-signaling and repair processes, contributing to balanced responses to oxidative and inflammatory stress.
Clinical trials
Multicenter, double-blind, randomized, placebo-controlled trial; 200 µg/day selenium as high-selenium (selenized) yeast; mean treatment about 4.5 years in the primary 1996 report, with longer blinded follow-up analyzed afterwards.
1,312 older adults from the eastern United States who had already had nonmelanoma skin cancer. This was a study in patients with a cancer history, so its results describe what happened in that group rather than what a supplement does for a healthy person.
The trial missed its primary endpoint: selenium did not protect against basal or squamous cell skin cancer. The fuller blinded follow-up went further and reported statistically significant increases in squamous cell carcinoma (hazard ratio 1.25, 95% confidence interval 1.03 to 1.51) and in total nonmelanoma skin cancer (hazard ratio 1.17, 1.02 to 1.34), concluding that selenium supplementation increases the risk of those skin cancers. Secondary analyses suggested lower total cancer incidence and lower prostate and colorectal cancer rates, especially in men with low baseline selenium, but these were exploratory findings that later trials did not confirm.
Randomized, double-blind, placebo-controlled trial; SelenoExcell® selenium yeast at 200 or 285 µg/day vs. L-selenomethionine 200 µg/day vs. placebo; 9 months supplementation plus 3-month washout.
69 healthy adult men. This was a small, men-only study, and it measured markers in urine rather than any health outcome.
The higher-dose selenium yeast group (285 µg/day) showed significant reductions in oxidative stress markers (urinary 8-OHdG down about 34% and 8-iso-PGF2alpha down about 28%), and both markers returned to their starting levels after the 3-month washout. Selenomethionine alone did not significantly change these markers. No changes in PSA or blood glucose were observed.
Large randomized, double-blind, placebo-controlled trial using L-selenomethionine 200 µg/day (not selenium yeast), with or without vitamin E; planned 7–12 years, stopped early.
35,533 generally healthy men aged 50–55+ in the US, Canada, and Puerto Rico.
In 35,533 men, selenium as selenomethionine did not prevent prostate cancer (hazard ratio 1.04); the investigators concluded that neither selenium nor vitamin E, alone or together, prevented prostate cancer at the doses and forms used. There was also a signal toward more type 2 diabetes in the selenium group (relative risk 1.07, 99% confidence interval 0.94 to 1.22, P = 0.16) that did not reach statistical significance but is the reason this trial is cited as a safety caution. Because this trial used pure selenomethionine rather than multi-species selenized yeast, it does not directly test SelenoExcell®, and its null result helped temper earlier selenium cancer-prevention enthusiasm.